QT
BNR

Quantbot Technologies’s Burning Rock Biotech BNR Stock Holding History

Quantbot Technologies’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,104
Closed -$61K – 1618
2022
Q2 		$61K Buy
+2,104
New +$94K 0.01% 1255
2022
Q1 		– Sell
-190
Closed -$18K – 1661
2021
Q4 		$18K Buy
+190
New +$26K ﹤0.01% 1237

Other funds holding BNR

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Quantbot Technologies's BNR Position: Q3 2022 in Review

Quantbot Technologies sold out of Burning Rock Biotech (BNR) in Q3 2022, closing a stake of 2,104 shares — an estimated $61K sold.

Quantbot Technologies first reported a position in BNR in Q4 2021 and held it in 2 quarters. The position peaked at $61K in Q2 2022. 52 funds tracked by Wall St. Rank hold BNR as of Q3 2022.

  • Quantbot Technologies reported no remaining Burning Rock Biotech position as of Q3 2022 after selling out during the quarter.
  • Quantbot Technologies sold 2,104 Burning Rock Biotech shares in Q3 2022, an estimated $61K.
  • Quantbot Technologies first reported a position in Burning Rock Biotech in Q4 2021 and held it in 2 quarters.
  • Quantbot Technologies's Burning Rock Biotech position peaked at $61K in Q2 2022.
  • 52 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q3 2022.

Based on Quantbot Technologies's 13F filing for Q3 2022, filed 7 Nov 2022.